• Lose 20% of your body weight on average in 1 year*. See safety info below.
• Targets two hormone receptors (GLP-1 and GIP) to maximize weight loss

*Patients without diabetes and with BMI ≥30, or BMI ≥27 plus a weight-related condition, lost an average of 20% of their body weight by 1 year in a 72-week trial studying the highest maintenance dose of Tirzepatide (15 mg), when paired with diet and exercise changes (compared to 3% with diet and exercise alone).